230 related articles for article (PubMed ID: 31678774)
1. Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease.
Lito S; Burda P; Baumgartner M; Sloan-Béna F; Táncos Z; Kobolák J; Dinnyés A; Krause KH; Marteyn A
Stem Cell Res; 2019 Dec; 41():101604. PubMed ID: 31678774
[TBL] [Abstract][Full Text] [Related]
2. Induced Pluripotent Stem Cells to Understand Mucopolysaccharidosis. I: Demonstration of a Migration Defect in Neural Precursors.
Lito S; Sidibe A; Ilmjarv S; Burda P; Baumgartner M; Wehrle-Haller B; Krause KH; Marteyn A
Cells; 2020 Dec; 9(12):. PubMed ID: 33287330
[No Abstract] [Full Text] [Related]
3. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).
Tolar J; Park IH; Xia L; Lees CJ; Peacock B; Webber B; McElmurry RT; Eide CR; Orchard PJ; Kyba M; Osborn MJ; Lund TC; Wagner JE; Daley GQ; Blazar BR
Blood; 2011 Jan; 117(3):839-47. PubMed ID: 21037085
[TBL] [Abstract][Full Text] [Related]
5. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.
Keeling KM; Brooks DA; Hopwood JJ; Li P; Thompson JN; Bedwell DM
Hum Mol Genet; 2001 Feb; 10(3):291-9. PubMed ID: 11159948
[TBL] [Abstract][Full Text] [Related]
6. Regulation of c-Myc Expression by Ahnak Promotes Induced Pluripotent Stem Cell Generation.
Lim HJ; Kim J; Park CH; Lee SA; Lee MR; Kim KS; Kim J; Bae YS
J Biol Chem; 2016 Jan; 291(2):752-61. PubMed ID: 26598518
[TBL] [Abstract][Full Text] [Related]
7. Mapping of IDUA gene variants in Pakistani patients with mucopolysaccharidosis type 1.
Zahoor MY; Cheema HA; Ijaz S; Anjum MN; Ramzan K; Bhinder MA
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1221-1227. PubMed ID: 31473686
[TBL] [Abstract][Full Text] [Related]
8. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
[TBL] [Abstract][Full Text] [Related]
9. Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I.
Suga M; Kondo T; Imamura K; Shibukawa R; Okanishi Y; Sagara Y; Tsukita K; Enami T; Furujo M; Saijo K; Nakamura Y; Osawa M; Saito MK; Yamanaka S; Inoue H
Stem Cell Res; 2019 Apr; 36():101406. PubMed ID: 30849633
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
[TBL] [Abstract][Full Text] [Related]
11. Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I.
Swaroop M; Brooks MJ; Gieser L; Swaroop A; Zheng W
Hum Mol Genet; 2018 Oct; 27(20):3612-3626. PubMed ID: 30052969
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cell line (RCMGi012-A) from fibroblasts of patient with mucopolysaccharidosis type VI.
Kondrateva E; Grigorieva O; Panchuk I; Bychkov I; Zakharova E; Tabakov V; Pozhitnova V; Voronina E; Shchagina O; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2023 Dec; 73():103259. PubMed ID: 38006675
[TBL] [Abstract][Full Text] [Related]
13. Generation of three iPSC lines from fibroblasts of a patient with Aicardi Goutières Syndrome mutated in TREX1.
Ferraro RM; Lanzi G; Masneri S; Barisani C; Piovani G; Savio G; Cattalini M; Galli J; Cereda C; Muzi-Falconi M; Orcesi S; Fazzi E; Giliani S
Stem Cell Res; 2019 Dec; 41():101580. PubMed ID: 31644995
[TBL] [Abstract][Full Text] [Related]
14. An induced pluripotent stem cell line (CSUi004-A) from skin fibroblasts of a healthy individual.
Wang L; Zhao H; Wu J; Ren J; Luo H; Zuo X; Chen Q; Tang Y
Stem Cell Res; 2021 May; 53():102336. PubMed ID: 33865102
[TBL] [Abstract][Full Text] [Related]
15. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
16. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood mononuclear cell-converted induced pluripotent stem cells (iPSCs) from an early onset Alzheimer's patient.
Lee HK; Morin P; Xia W
Stem Cell Res; 2016 Mar; 16(2):213-5. PubMed ID: 27345971
[TBL] [Abstract][Full Text] [Related]
18. Mutation Analysis of the
Kamranjam M; Alaei M
Genet Test Mol Biomarkers; 2019 Aug; 23(8):515-522. PubMed ID: 31298590
[No Abstract] [Full Text] [Related]
19. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
[TBL] [Abstract][Full Text] [Related]
20. Generation of an induced pluripotent stem cell (iPSC) line, DHMCi005-A, from a patient with CALFAN syndrome due to mutations in SCYL1.
Lenz D; Staufner C; Wächter S; Hagedorn M; Ebersold J; Göhring G; Kölker S; Hoffmann GF; Jung-Klawitter S
Stem Cell Res; 2019 May; 37():101428. PubMed ID: 30959346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
